(1S,4S,5S)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]heptane-4,5-diol

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氧环庚烷
• 英文名称: (1S,4S,5S)-3-(hydroxymethyl)-2,7-dioxabicyclo[4.1.0]heptane-4,5-diol
• 化学式: C₆H₁₀O₅
• 分子量: 162.14
• InChiKey: HFWNXHAGJNLQRO-OOMLUFPTSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.6
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  82.4
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• NOVEL CARBOHYDRATE ESTERS AND POLYOL ESTERS AS PLASTICIZERS FOR POLYMERS, COMPOSITIONS AND ARTICLES INCLUDING SUCH PLASTICIZERS AND METHODS OF USING THE SAME
  申请人：EASTMAN CHEMICAL COMPANY

  公开号：EP1465944B1

  公开（公告）日：2015-02-25
• TANNASE
  申请人：Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung

  公开号：EP1763578B1

  公开（公告）日：2014-09-10
• PHARMACEUTICAL COMPOSITION COMPRISING MONOSACCHARIDE AND/OR POLYSACCHARIDE AND USES OF MONOSACCHARIDE AND POLYSACCHARIDE
  申请人：LEE Jen-Ai

  公开号：US20160263146A1

  公开（公告）日：2016-09-15

  The present invention discloses a pharmaceutical composition comprising a monosaccharide and/or polysaccharide as an active ingredient thereof, for decreasing the accumulation of di-carbonyl compounds in the human body. Said monosaccharide is a monomer of said polysaccharide, and the molecular weight of the polysaccharide ranges from 29 kDa to 36 kDa. The monosaccharide and/or polysaccharide can be used to prevent or treat nephritis or diseases associated with di-carbonyl compounds, or other diseases caused by carbonyl-stress, and can also be used to make the relevant drug.